Intrinsic Therapeutics Announces Initial Release of Its Next Generation Barricaid Narrow Anchor Device Designed to Reduce Reherniation After Back Surgery

BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid® Bone-Anchored Annular Closure Device. The new version of the Barricaid device is 25 percent smaller than the standard...